Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vitamin D & Omega 3 to be Studied in Disease Prevention Trial - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Vitamin D & Omega 3 to be Studied in Disease Prevention Trial

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Researchers will conduct a large clinical trial designed to evaluate the impact of vitamin D and omega 3 in reducing the risk of cancer and heart disease among people with no prior history of such ailments. The National Institutes of Health (NIH) will fund this $20 million study—dubbed the Vitamin D and Omega 3 Trial (VITAL). Scientists at Harvard Medical School and the Brigham and Women’s Hospital in Boston, MA, intend to evaluate 20,000 U.S men and women over a period of five years. Women ages 65 or older and men ages 60 or older will take an estimated 2000 IU of vitamin D and/or about 1 gram of omega 3 fatty acids from fish oil either alone or in combination. Pharmavite, Northridge, CA, is providing the vitamin D supplements and Ocean Nutrition Canada, Dartmouth, Nova Scotia, is supplying the fish oil. Recruitment for the study will begin in January 2010.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics